Pancreatic Adenocarcinoma Associated With a Germline RAD51C Mutation
Division
North Florida
Hospital
Osceola Regional Medical Center
Document Type
Case Report
Publication Date
4-28-2026
Keywords
RAD51C mutation, genetic testing, hereditary cancer syndrome, homologous recombination deficiency, pancreatic adenocarcinoma
Disciplines
Digestive System Diseases | Gastroenterology | Internal Medicine | Medicine and Health Sciences | Neoplasms | Skin and Connective Tissue Diseases
Abstract
Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of cancer-related mortality in the United States, with a 5-year survival of ∼10%-13%. Although 5%-10% of PDAC cases arise from pathogenic germline variants in cancer-predisposition genes, association with
Publisher or Conference
ACG Case Reports Journal
Recommended Citation
Lawrence A, Villanueva I, Parikh J, Mandalia A. Pancreatic Adenocarcinoma Associated With a Germline RAD51C Mutation. ACG Case Rep J. 2026;13(5):e02103. Published 2026 Apr 28. doi:10.14309/crj.0000000000002103